Global Octreotide Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Description

According to our (Global Info Research) latest study, the global Octreotide market size was valued at USD 3 million in 2023 and is forecast to a readjusted size of USD 3 million by 2030 with a CAGR of -2.7% during review period.

Octreotide is an octapeptide that mimics natural somatostatin pharmacologically，it is a more potent inhibitor of growth hormone, glucagon, and insulin than the natural hormone. Usually in the form of a salt of acetic acid.

Global Octreotide key players include Novartis, SUN, Tiantaishan pharmaceutical, Sinopharm A-Think, Sihuan Pharmaceutical, etc. Global top five manufacturers hold a share over 90%.

Europe is the largest market, with a share over 65%, followed by India and China, both have a share over 30%.

The Global Info Research report includes an overview of the development of the Octreotide industry chain, the market status of Treating Severe Diarrhea (Octreotide Injection, Octreotide Powder), Treating Acromegaly (Octreotide Injection, Octreotide Powder), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Octreotide.

Regionally, the report analyzes the Octreotide markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Octreotide market, with robust domestic demand, supportive policies, and a strong manufacturing base.

Key Features:
The report presents comprehensive understanding of the Octreotide market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Octreotide industry.

The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (Gram), revenue generated, and market share of different by Type (e.g., Octreotide Injection, Octreotide Powder).

Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Octreotide market.

Regional Analysis: The report involves examining the Octreotide market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.

Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Octreotide market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.

The report also involves a more granular approach to Octreotide:
Company Analysis: Report covers individual Octreotide manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.

Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Octreotide This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Treating Severe Diarrhea, Treating Acromegaly).

Technology Analysis: Report covers specific technologies relevant to Octreotide. It assesses the current state, advancements, and potential future developments in Octreotide areas.

Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Octreotide market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.

Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.

Market Segmentation
Octreotide market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.

Market segment by Type
    Octreotide Injection
    Octreotide Powder
    Octreotide Microspheres

Market segment by Application
    Treating Severe Diarrhea
    Treating Acromegaly
    Others

Major players covered
    Novartis
    Sun Pharmaceutical
    Chengdu Tiantaishan pharmaceutical
    Sinopharm A-Think Pharmaceuticals
    Sihuan Pharmaceutical Holdings Group
    Shanghai Soho-Yiming Pharmaceuticals
    Yibin Pharmaceutical

Market segment by region, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Octreotide product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Octreotide, with price, sales, revenue and global market share of Octreotide from 2019 to 2024.
Chapter 3, the Octreotide competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Octreotide breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Octreotide market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Octreotide.
Chapter 14 and 15, to describe Octreotide sales channel, distributors, customers, research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Octreotide
    1.2 Market Estimation Caveats and Base Year
    1.3 Market Analysis by Type
        1.3.1 Overview: Global Octreotide Consumption Value by Type: 2019 Versus 2023 Versus 2030
        1.3.2 Octreotide Injection
        1.3.3 Octreotide Powder
        1.3.4 Octreotide Microspheres
    1.4 Market Analysis by Application
        1.4.1 Overview: Global Octreotide Consumption Value by Application: 2019 Versus 2023 Versus 2030
        1.4.2 Treating Severe Diarrhea
        1.4.3 Treating Acromegaly
        1.4.4 Others
    1.5 Global Octreotide Market Size & Forecast
        1.5.1 Global Octreotide Consumption Value (2019 & 2023 & 2030)
        1.5.2 Global Octreotide Sales Quantity (2019-2030)
        1.5.3 Global Octreotide Average Price (2019-2030)

2 Manufacturers Profiles
    2.1 Novartis
        2.1.1 Novartis Details
        2.1.2 Novartis Major Business
        2.1.3 Novartis Octreotide Product and Services
        2.1.4 Novartis Octreotide Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.1.5 Novartis Recent Developments/Updates
    2.2 Sun Pharmaceutical
        2.2.1 Sun Pharmaceutical Details
        2.2.2 Sun Pharmaceutical Major Business
        2.2.3 Sun Pharmaceutical Octreotide Product and Services
        2.2.4 Sun Pharmaceutical Octreotide Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.2.5 Sun Pharmaceutical Recent Developments/Updates
    2.3 Chengdu Tiantaishan pharmaceutical
        2.3.1 Chengdu Tiantaishan pharmaceutical Details
        2.3.2 Chengdu Tiantaishan pharmaceutical Major Business
        2.3.3 Chengdu Tiantaishan pharmaceutical Octreotide Product and Services
        2.3.4 Chengdu Tiantaishan pharmaceutical Octreotide Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.3.5 Chengdu Tiantaishan pharmaceutical Recent Developments/Updates
    2.4 Sinopharm A-Think Pharmaceuticals
        2.4.1 Sinopharm A-Think Pharmaceuticals Details
        2.4.2 Sinopharm A-Think Pharmaceuticals Major Business
        2.4.3 Sinopharm A-Think Pharmaceuticals Octreotide Product and Services
        2.4.4 Sinopharm A-Think Pharmaceuticals Octreotide Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.4.5 Sinopharm A-Think Pharmaceuticals Recent Developments/Updates
    2.5 Sihuan Pharmaceutical Holdings Group
        2.5.1 Sihuan Pharmaceutical Holdings Group Details
        2.5.2 Sihuan Pharmaceutical Holdings Group Major Business
        2.5.3 Sihuan Pharmaceutical Holdings Group Octreotide Product and Services
        2.5.4 Sihuan Pharmaceutical Holdings Group Octreotide Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.5.5 Sihuan Pharmaceutical Holdings Group Recent Developments/Updates
    2.6 Shanghai Soho-Yiming Pharmaceuticals
        2.6.1 Shanghai Soho-Yiming Pharmaceuticals Details
        2.6.2 Shanghai Soho-Yiming Pharmaceuticals Major Business
        2.6.3 Shanghai Soho-Yiming Pharmaceuticals Octreotide Product and Services
        2.6.4 Shanghai Soho-Yiming Pharmaceuticals Octreotide Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.6.5 Shanghai Soho-Yiming Pharmaceuticals Recent Developments/Updates
    2.7 Yibin Pharmaceutical
        2.7.1 Yibin Pharmaceutical Details
        2.7.2 Yibin Pharmaceutical Major Business
        2.7.3 Yibin Pharmaceutical Octreotide Product and Services
        2.7.4 Yibin Pharmaceutical Octreotide Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.7.5 Yibin Pharmaceutical Recent Developments/Updates

3 Competitive Environment: Octreotide by Manufacturer
    3.1 Global Octreotide Sales Quantity by Manufacturer (2019-2024)
    3.2 Global Octreotide Revenue by Manufacturer (2019-2024)
    3.3 Global Octreotide Average Price by Manufacturer (2019-2024)
    3.4 Market Share Analysis (2023)
        3.4.1 Producer Shipments of Octreotide by Manufacturer Revenue ($MM) and Market Share (%): 2023
        3.4.2 Top 3 Octreotide Manufacturer Market Share in 2023
        3.4.2 Top 6 Octreotide Manufacturer Market Share in 2023
    3.5 Octreotide Market: Overall Company Footprint Analysis
        3.5.1 Octreotide Market: Region Footprint
        3.5.2 Octreotide Market: Company Product Type Footprint
        3.5.3 Octreotide Market: Company Product Application Footprint
    3.6 New Market Entrants and Barriers to Market Entry
    3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region
    4.1 Global Octreotide Market Size by Region
        4.1.1 Global Octreotide Sales Quantity by Region (2019-2030)
        4.1.2 Global Octreotide Consumption Value by Region (2019-2030)
        4.1.3 Global Octreotide Average Price by Region (2019-2030)
    4.2 North America Octreotide Consumption Value (2019-2030)
    4.3 Europe Octreotide Consumption Value (2019-2030)
    4.4 Asia-Pacific Octreotide Consumption Value (2019-2030)
    4.5 South America Octreotide Consumption Value (2019-2030)
    4.6 Middle East and Africa Octreotide Consumption Value (2019-2030)

5 Market Segment by Type
    5.1 Global Octreotide Sales Quantity by Type (2019-2030)
    5.2 Global Octreotide Consumption Value by Type (2019-2030)
    5.3 Global Octreotide Average Price by Type (2019-2030)

6 Market Segment by Application
    6.1 Global Octreotide Sales Quantity by Application (2019-2030)
    6.2 Global Octreotide Consumption Value by Application (2019-2030)
    6.3 Global Octreotide Average Price by Application (2019-2030)

7 North America
    7.1 North America Octreotide Sales Quantity by Type (2019-2030)
    7.2 North America Octreotide Sales Quantity by Application (2019-2030)
    7.3 North America Octreotide Market Size by Country
        7.3.1 North America Octreotide Sales Quantity by Country (2019-2030)
        7.3.2 North America Octreotide Consumption Value by Country (2019-2030)
        7.3.3 United States Market Size and Forecast (2019-2030)
        7.3.4 Canada Market Size and Forecast (2019-2030)
        7.3.5 Mexico Market Size and Forecast (2019-2030)

8 Europe
    8.1 Europe Octreotide Sales Quantity by Type (2019-2030)
    8.2 Europe Octreotide Sales Quantity by Application (2019-2030)
    8.3 Europe Octreotide Market Size by Country
        8.3.1 Europe Octreotide Sales Quantity by Country (2019-2030)
        8.3.2 Europe Octreotide Consumption Value by Country (2019-2030)
        8.3.3 Germany Market Size and Forecast (2019-2030)
        8.3.4 France Market Size and Forecast (2019-2030)
        8.3.5 United Kingdom Market Size and Forecast (2019-2030)
        8.3.6 Russia Market Size and Forecast (2019-2030)
        8.3.7 Italy Market Size and Forecast (2019-2030)

9 Asia-Pacific
    9.1 Asia-Pacific Octreotide Sales Quantity by Type (2019-2030)
    9.2 Asia-Pacific Octreotide Sales Quantity by Application (2019-2030)
    9.3 Asia-Pacific Octreotide Market Size by Region
        9.3.1 Asia-Pacific Octreotide Sales Quantity by Region (2019-2030)
        9.3.2 Asia-Pacific Octreotide Consumption Value by Region (2019-2030)
        9.3.3 China Market Size and Forecast (2019-2030)
        9.3.4 Japan Market Size and Forecast (2019-2030)
        9.3.5 Korea Market Size and Forecast (2019-2030)
        9.3.6 India Market Size and Forecast (2019-2030)
        9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
        9.3.8 Australia Market Size and Forecast (2019-2030)

10 South America
    10.1 South America Octreotide Sales Quantity by Type (2019-2030)
    10.2 South America Octreotide Sales Quantity by Application (2019-2030)
    10.3 South America Octreotide Market Size by Country
        10.3.1 South America Octreotide Sales Quantity by Country (2019-2030)
        10.3.2 South America Octreotide Consumption Value by Country (2019-2030)
        10.3.3 Brazil Market Size and Forecast (2019-2030)
        10.3.4 Argentina Market Size and Forecast (2019-2030)

11 Middle East & Africa
    11.1 Middle East & Africa Octreotide Sales Quantity by Type (2019-2030)
    11.2 Middle East & Africa Octreotide Sales Quantity by Application (2019-2030)
    11.3 Middle East & Africa Octreotide Market Size by Country
        11.3.1 Middle East & Africa Octreotide Sales Quantity by Country (2019-2030)
        11.3.2 Middle East & Africa Octreotide Consumption Value by Country (2019-2030)
        11.3.3 Turkey Market Size and Forecast (2019-2030)
        11.3.4 Egypt Market Size and Forecast (2019-2030)
        11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
        11.3.6 South Africa Market Size and Forecast (2019-2030)

12 Market Dynamics
    12.1 Octreotide Market Drivers
    12.2 Octreotide Market Restraints
    12.3 Octreotide Trends Analysis
    12.4 Porters Five Forces Analysis
        12.4.1 Threat of New Entrants
        12.4.2 Bargaining Power of Suppliers
        12.4.3 Bargaining Power of Buyers
        12.4.4 Threat of Substitutes
        12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain
    13.1 Raw Material of Octreotide and Key Manufacturers
    13.2 Manufacturing Costs Percentage of Octreotide
    13.3 Octreotide Production Process
    13.4 Octreotide Industrial Chain

14 Shipments by Distribution Channel
    14.1 Sales Channel
        14.1.1 Direct to End-User
        14.1.2 Distributors
    14.2 Octreotide Typical Distributors
    14.3 Octreotide Typical Customers

15 Research Findings and Conclusion

16 Appendix
    16.1 Methodology
    16.2 Research Process and Data Source
    16.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Octreotide Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Table 2. Global Octreotide Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
    Table 3. Novartis Basic Information, Manufacturing Base and Competitors
    Table 4. Novartis Major Business
    Table 5. Novartis Octreotide Product and Services
    Table 6. Novartis Octreotide Sales Quantity (Gram), Average Price (USD/Gram), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 7. Novartis Recent Developments/Updates
    Table 8. Sun Pharmaceutical Basic Information, Manufacturing Base and Competitors
    Table 9. Sun Pharmaceutical Major Business
    Table 10. Sun Pharmaceutical Octreotide Product and Services
    Table 11. Sun Pharmaceutical Octreotide Sales Quantity (Gram), Average Price (USD/Gram), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 12. Sun Pharmaceutical Recent Developments/Updates
    Table 13. Chengdu Tiantaishan pharmaceutical Basic Information, Manufacturing Base and Competitors
    Table 14. Chengdu Tiantaishan pharmaceutical Major Business
    Table 15. Chengdu Tiantaishan pharmaceutical Octreotide Product and Services
    Table 16. Chengdu Tiantaishan pharmaceutical Octreotide Sales Quantity (Gram), Average Price (USD/Gram), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 17. Chengdu Tiantaishan pharmaceutical Recent Developments/Updates
    Table 18. Sinopharm A-Think Pharmaceuticals Basic Information, Manufacturing Base and Competitors
    Table 19. Sinopharm A-Think Pharmaceuticals Major Business
    Table 20. Sinopharm A-Think Pharmaceuticals Octreotide Product and Services
    Table 21. Sinopharm A-Think Pharmaceuticals Octreotide Sales Quantity (Gram), Average Price (USD/Gram), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 22. Sinopharm A-Think Pharmaceuticals Recent Developments/Updates
    Table 23. Sihuan Pharmaceutical Holdings Group Basic Information, Manufacturing Base and Competitors
    Table 24. Sihuan Pharmaceutical Holdings Group Major Business
    Table 25. Sihuan Pharmaceutical Holdings Group Octreotide Product and Services
    Table 26. Sihuan Pharmaceutical Holdings Group Octreotide Sales Quantity (Gram), Average Price (USD/Gram), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 27. Sihuan Pharmaceutical Holdings Group Recent Developments/Updates
    Table 28. Shanghai Soho-Yiming Pharmaceuticals Basic Information, Manufacturing Base and Competitors
    Table 29. Shanghai Soho-Yiming Pharmaceuticals Major Business
    Table 30. Shanghai Soho-Yiming Pharmaceuticals Octreotide Product and Services
    Table 31. Shanghai Soho-Yiming Pharmaceuticals Octreotide Sales Quantity (Gram), Average Price (USD/Gram), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 32. Shanghai Soho-Yiming Pharmaceuticals Recent Developments/Updates
    Table 33. Yibin Pharmaceutical Basic Information, Manufacturing Base and Competitors
    Table 34. Yibin Pharmaceutical Major Business
    Table 35. Yibin Pharmaceutical Octreotide Product and Services
    Table 36. Yibin Pharmaceutical Octreotide Sales Quantity (Gram), Average Price (USD/Gram), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 37. Yibin Pharmaceutical Recent Developments/Updates
    Table 38. Global Octreotide Sales Quantity by Manufacturer (2019-2024) & (Gram)
    Table 39. Global Octreotide Revenue by Manufacturer (2019-2024) & (USD Million)
    Table 40. Global Octreotide Average Price by Manufacturer (2019-2024) & (USD/Gram)
    Table 41. Market Position of Manufacturers in Octreotide, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
    Table 42. Head Office and Octreotide Production Site of Key Manufacturer
    Table 43. Octreotide Market: Company Product Type Footprint
    Table 44. Octreotide Market: Company Product Application Footprint
    Table 45. Octreotide New Market Entrants and Barriers to Market Entry
    Table 46. Octreotide Mergers, Acquisition, Agreements, and Collaborations
    Table 47. Global Octreotide Sales Quantity by Region (2019-2024) & (Gram)
    Table 48. Global Octreotide Sales Quantity by Region (2025-2030) & (Gram)
    Table 49. Global Octreotide Consumption Value by Region (2019-2024) & (USD Million)
    Table 50. Global Octreotide Consumption Value by Region (2025-2030) & (USD Million)
    Table 51. Global Octreotide Average Price by Region (2019-2024) & (USD/Gram)
    Table 52. Global Octreotide Average Price by Region (2025-2030) & (USD/Gram)
    Table 53. Global Octreotide Sales Quantity by Type (2019-2024) & (Gram)
    Table 54. Global Octreotide Sales Quantity by Type (2025-2030) & (Gram)
    Table 55. Global Octreotide Consumption Value by Type (2019-2024) & (USD Million)
    Table 56. Global Octreotide Consumption Value by Type (2025-2030) & (USD Million)
    Table 57. Global Octreotide Average Price by Type (2019-2024) & (USD/Gram)
    Table 58. Global Octreotide Average Price by Type (2025-2030) & (USD/Gram)
    Table 59. Global Octreotide Sales Quantity by Application (2019-2024) & (Gram)
    Table 60. Global Octreotide Sales Quantity by Application (2025-2030) & (Gram)
    Table 61. Global Octreotide Consumption Value by Application (2019-2024) & (USD Million)
    Table 62. Global Octreotide Consumption Value by Application (2025-2030) & (USD Million)
    Table 63. Global Octreotide Average Price by Application (2019-2024) & (USD/Gram)
    Table 64. Global Octreotide Average Price by Application (2025-2030) & (USD/Gram)
    Table 65. North America Octreotide Sales Quantity by Type (2019-2024) & (Gram)
    Table 66. North America Octreotide Sales Quantity by Type (2025-2030) & (Gram)
    Table 67. North America Octreotide Sales Quantity by Application (2019-2024) & (Gram)
    Table 68. North America Octreotide Sales Quantity by Application (2025-2030) & (Gram)
    Table 69. North America Octreotide Sales Quantity by Country (2019-2024) & (Gram)
    Table 70. North America Octreotide Sales Quantity by Country (2025-2030) & (Gram)
    Table 71. North America Octreotide Consumption Value by Country (2019-2024) & (USD Million)
    Table 72. North America Octreotide Consumption Value by Country (2025-2030) & (USD Million)
    Table 73. Europe Octreotide Sales Quantity by Type (2019-2024) & (Gram)
    Table 74. Europe Octreotide Sales Quantity by Type (2025-2030) & (Gram)
    Table 75. Europe Octreotide Sales Quantity by Application (2019-2024) & (Gram)
    Table 76. Europe Octreotide Sales Quantity by Application (2025-2030) & (Gram)
    Table 77. Europe Octreotide Sales Quantity by Country (2019-2024) & (Gram)
    Table 78. Europe Octreotide Sales Quantity by Country (2025-2030) & (Gram)
    Table 79. Europe Octreotide Consumption Value by Country (2019-2024) & (USD Million)
    Table 80. Europe Octreotide Consumption Value by Country (2025-2030) & (USD Million)
    Table 81. Asia-Pacific Octreotide Sales Quantity by Type (2019-2024) & (Gram)
    Table 82. Asia-Pacific Octreotide Sales Quantity by Type (2025-2030) & (Gram)
    Table 83. Asia-Pacific Octreotide Sales Quantity by Application (2019-2024) & (Gram)
    Table 84. Asia-Pacific Octreotide Sales Quantity by Application (2025-2030) & (Gram)
    Table 85. Asia-Pacific Octreotide Sales Quantity by Region (2019-2024) & (Gram)
    Table 86. Asia-Pacific Octreotide Sales Quantity by Region (2025-2030) & (Gram)
    Table 87. Asia-Pacific Octreotide Consumption Value by Region (2019-2024) & (USD Million)
    Table 88. Asia-Pacific Octreotide Consumption Value by Region (2025-2030) & (USD Million)
    Table 89. South America Octreotide Sales Quantity by Type (2019-2024) & (Gram)
    Table 90. South America Octreotide Sales Quantity by Type (2025-2030) & (Gram)
    Table 91. South America Octreotide Sales Quantity by Application (2019-2024) & (Gram)
    Table 92. South America Octreotide Sales Quantity by Application (2025-2030) & (Gram)
    Table 93. South America Octreotide Sales Quantity by Country (2019-2024) & (Gram)
    Table 94. South America Octreotide Sales Quantity by Country (2025-2030) & (Gram)
    Table 95. South America Octreotide Consumption Value by Country (2019-2024) & (USD Million)
    Table 96. South America Octreotide Consumption Value by Country (2025-2030) & (USD Million)
    Table 97. Middle East & Africa Octreotide Sales Quantity by Type (2019-2024) & (Gram)
    Table 98. Middle East & Africa Octreotide Sales Quantity by Type (2025-2030) & (Gram)
    Table 99. Middle East & Africa Octreotide Sales Quantity by Application (2019-2024) & (Gram)
    Table 100. Middle East & Africa Octreotide Sales Quantity by Application (2025-2030) & (Gram)
    Table 101. Middle East & Africa Octreotide Sales Quantity by Region (2019-2024) & (Gram)
    Table 102. Middle East & Africa Octreotide Sales Quantity by Region (2025-2030) & (Gram)
    Table 103. Middle East & Africa Octreotide Consumption Value by Region (2019-2024) & (USD Million)
    Table 104. Middle East & Africa Octreotide Consumption Value by Region (2025-2030) & (USD Million)
    Table 105. Octreotide Raw Material
    Table 106. Key Manufacturers of Octreotide Raw Materials
    Table 107. Octreotide Typical Distributors
    Table 108. Octreotide Typical Customers
List of Figures
    Figure 1. Octreotide Picture
    Figure 2. Global Octreotide Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Figure 3. Global Octreotide Consumption Value Market Share by Type in 2023
    Figure 4. Octreotide Injection Examples
    Figure 5. Octreotide Powder Examples
    Figure 6. Octreotide Microspheres Examples
    Figure 7. Global Octreotide Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
    Figure 8. Global Octreotide Consumption Value Market Share by Application in 2023
    Figure 9. Treating Severe Diarrhea Examples
    Figure 10. Treating Acromegaly Examples
    Figure 11. Others Examples
    Figure 12. Global Octreotide Consumption Value, (USD Million): 2019 & 2023 & 2030
    Figure 13. Global Octreotide Consumption Value and Forecast (2019-2030) & (USD Million)
    Figure 14. Global Octreotide Sales Quantity (2019-2030) & (Gram)
    Figure 15. Global Octreotide Average Price (2019-2030) & (USD/Gram)
    Figure 16. Global Octreotide Sales Quantity Market Share by Manufacturer in 2023
    Figure 17. Global Octreotide Consumption Value Market Share by Manufacturer in 2023
    Figure 18. Producer Shipments of Octreotide by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
    Figure 19. Top 3 Octreotide Manufacturer (Consumption Value) Market Share in 2023
    Figure 20. Top 6 Octreotide Manufacturer (Consumption Value) Market Share in 2023
    Figure 21. Global Octreotide Sales Quantity Market Share by Region (2019-2030)
    Figure 22. Global Octreotide Consumption Value Market Share by Region (2019-2030)
    Figure 23. North America Octreotide Consumption Value (2019-2030) & (USD Million)
    Figure 24. Europe Octreotide Consumption Value (2019-2030) & (USD Million)
    Figure 25. Asia-Pacific Octreotide Consumption Value (2019-2030) & (USD Million)
    Figure 26. South America Octreotide Consumption Value (2019-2030) & (USD Million)
    Figure 27. Middle East & Africa Octreotide Consumption Value (2019-2030) & (USD Million)
    Figure 28. Global Octreotide Sales Quantity Market Share by Type (2019-2030)
    Figure 29. Global Octreotide Consumption Value Market Share by Type (2019-2030)
    Figure 30. Global Octreotide Average Price by Type (2019-2030) & (USD/Gram)
    Figure 31. Global Octreotide Sales Quantity Market Share by Application (2019-2030)
    Figure 32. Global Octreotide Consumption Value Market Share by Application (2019-2030)
    Figure 33. Global Octreotide Average Price by Application (2019-2030) & (USD/Gram)
    Figure 34. North America Octreotide Sales Quantity Market Share by Type (2019-2030)
    Figure 35. North America Octreotide Sales Quantity Market Share by Application (2019-2030)
    Figure 36. North America Octreotide Sales Quantity Market Share by Country (2019-2030)
    Figure 37. North America Octreotide Consumption Value Market Share by Country (2019-2030)
    Figure 38. United States Octreotide Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 39. Canada Octreotide Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 40. Mexico Octreotide Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 41. Europe Octreotide Sales Quantity Market Share by Type (2019-2030)
    Figure 42. Europe Octreotide Sales Quantity Market Share by Application (2019-2030)
    Figure 43. Europe Octreotide Sales Quantity Market Share by Country (2019-2030)
    Figure 44. Europe Octreotide Consumption Value Market Share by Country (2019-2030)
    Figure 45. Germany Octreotide Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 46. France Octreotide Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 47. United Kingdom Octreotide Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 48. Russia Octreotide Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 49. Italy Octreotide Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 50. Asia-Pacific Octreotide Sales Quantity Market Share by Type (2019-2030)
    Figure 51. Asia-Pacific Octreotide Sales Quantity Market Share by Application (2019-2030)
    Figure 52. Asia-Pacific Octreotide Sales Quantity Market Share by Region (2019-2030)
    Figure 53. Asia-Pacific Octreotide Consumption Value Market Share by Region (2019-2030)
    Figure 54. China Octreotide Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 55. Japan Octreotide Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 56. Korea Octreotide Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 57. India Octreotide Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 58. Southeast Asia Octreotide Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 59. Australia Octreotide Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 60. South America Octreotide Sales Quantity Market Share by Type (2019-2030)
    Figure 61. South America Octreotide Sales Quantity Market Share by Application (2019-2030)
    Figure 62. South America Octreotide Sales Quantity Market Share by Country (2019-2030)
    Figure 63. South America Octreotide Consumption Value Market Share by Country (2019-2030)
    Figure 64. Brazil Octreotide Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 65. Argentina Octreotide Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 66. Middle East & Africa Octreotide Sales Quantity Market Share by Type (2019-2030)
    Figure 67. Middle East & Africa Octreotide Sales Quantity Market Share by Application (2019-2030)
    Figure 68. Middle East & Africa Octreotide Sales Quantity Market Share by Region (2019-2030)
    Figure 69. Middle East & Africa Octreotide Consumption Value Market Share by Region (2019-2030)
    Figure 70. Turkey Octreotide Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 71. Egypt Octreotide Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 72. Saudi Arabia Octreotide Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 73. South Africa Octreotide Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 74. Octreotide Market Drivers
    Figure 75. Octreotide Market Restraints
    Figure 76. Octreotide Market Trends
    Figure 77. Porters Five Forces Analysis
    Figure 78. Manufacturing Cost Structure Analysis of Octreotide in 2023
    Figure 79. Manufacturing Process Analysis of Octreotide
    Figure 80. Octreotide Industrial Chain
    Figure 81. Sales Quantity Channel: Direct to End-User vs Distributors
    Figure 82. Direct Channel Pros & Cons
    Figure 83. Indirect Channel Pros & Cons
    Figure 84. Methodology
    Figure 85. Research Process and Data Source

Companies Mentioned

Novartis
Sun Pharmaceutical
Chengdu Tiantaishan pharmaceutical
Sinopharm A-Think Pharmaceuticals
Sihuan Pharmaceutical Holdings Group
Shanghai Soho-Yiming Pharmaceuticals
Yibin Pharmaceutical